BioMarin Pharmaceutical Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported total net Revenue was $501,693,000 against $429,485,000 a year ago. Income from operations was $11,672,000 against loss from operations of $40,945,000 a year ago. Net income was $12,941,000 against net loss of $29,183,000 a year ago. Basic per share was $0.07 against basic loss per share of $0.16 a year ago. Diluted per share was $0.07 against diluted loss per share of $0.16 a year ago. For the six months, the company reported total net Revenue was $987,723,000 against $931,554,000 a year ago. Income from operations was $36,758,000 against $64,016,000 a year ago. Net income was $30,312,000 against $52,198,000 a year ago. Basic per share was $0.17 against $0.29 a year ago. Diluted per share was $0.16 against $0.28 a year ago.